PROFOUND MEDICAL CORP. Selling, General and Administrative Expense
PROFOUND MEDICAL CORP. (PROF) reported Selling, General and Administrative Expense of $7.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-06
- PROFOUND MEDICAL CORP. selling, general and administrative expense for the quarter ending 2026-06-30 was $7.36M, a 21.09% decline year-over-year.
- PROFOUND MEDICAL CORP. selling, general and administrative expense for the quarter ending 2026-03-31 was $6.59M, a 19.73% decline year-over-year.
- PROFOUND MEDICAL CORP. selling, general and administrative expense for the quarter ending 2025-12-31 was $7.09M, a 6.46% increase year-over-year.
- PROFOUND MEDICAL CORP. selling, general and administrative expense for the quarter ending 2025-09-30 was $7.43M, a 12.18% increase year-over-year.
- PROFOUND MEDICAL CORP. selling, general and administrative expense for fiscal 2025 was $32.05M, a 38.54% increase from fiscal 2024.
- PROFOUND MEDICAL CORP. selling, general and administrative expense for fiscal 2024 was $23.13M, a 24.79% increase from fiscal 2023.
- PROFOUND MEDICAL CORP. selling, general and administrative expense for fiscal 2023 was $18.54M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.36M 10-Q · filed 2026-08-06 | $13.95M 10-Q · filed 2026-08-06 | $21.04M derived: sum of 3 quarters · filed 2026-08-06 | $28.46M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $6.59M 10-Q · filed 2026-05-07 | $13.68M derived: sum of 2 quarters · filed 2026-05-07 | $21.11M derived: sum of 3 quarters · filed 2026-05-07 | $30.43M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $14.51M derived: sum of 2 quarters · filed 2026-03-05 | $23.84M derived: sum of 3 quarters · filed 2026-08-06 | $32.05M 10-K · filed 2026-03-05 |
| 2025-09-30 | $7.43M 10-Q · filed 2025-11-13 | $16.75M derived: sum of 2 quarters · filed 2026-08-06 | $24.96M 10-Q · filed 2025-11-13 | $31.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $9.33M 10-Q · filed 2026-08-06 | $17.54M 10-Q · filed 2026-08-06 | $24.20M derived: sum of 3 quarters · filed 2026-08-06 | $30.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $8.21M 10-Q · filed 2026-05-07 | $14.87M derived: sum of 2 quarters · filed 2026-05-07 | $21.49M derived: sum of 3 quarters · filed 2026-05-07 | $26.55M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $6.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $13.28M derived: sum of 2 quarters · filed 2026-03-05 | $18.34M derived: sum of 3 quarters · filed 2026-03-05 | $23.13M 10-K · filed 2026-03-05 |
| 2024-09-30 | $6.62M 10-Q · filed 2025-11-13 | $11.68M derived: sum of 2 quarters · filed 2025-11-13 | $16.48M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $5.06M 10-Q · filed 2025-08-14 | $9.86M 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | $4.80M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $18.54M 10-K · filed 2025-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |